0000950123-19-000385.txt : 20190128
0000950123-19-000385.hdr.sgml : 20190128
20190128160602
ACCESSION NUMBER: 0000950123-19-000385
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190128
DATE AS OF CHANGE: 20190128
EFFECTIVENESS DATE: 20190128
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: TRV GP II, LLC
CENTRAL INDEX KEY: 0001614073
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18419
FILM NUMBER: 19545510
BUSINESS ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-585-2000
MAIL ADDRESS:
STREET 1: THIRD ROCK VENTURES
STREET 2: 29 NEWBURY STREET, 3RD FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001614073
XXXXXXXX
12-31-2018
12-31-2018
TRV GP II, LLC
THIRD ROCK VENTURES
29 NEWBURY STREET, 3RD FLOOR
Boston
MA
02116
13F HOLDINGS REPORT
028-18419
N
Kevin Gillis
Chief Financial Officer
617-585-2000
/s/ Kevin Gillis
Boston
MA
01-28-2019
3
4
100646
false
1
028-18439
Mark Levin
2
028-18438
Kevin P. Starr
3
028-18419
Robert I. Tepper
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
SAGE THERAPEUTICS, INC.
COM
78667J108
3579
37362
SH
DFND
1,2,3
37362
0
0
JOUNCE THERAPEUTICS, INC.
COM
481116101
34476
10230349
SH
DFND
1,2,3
10230349
0
0
BLUEPRINT MEDICINES CORPORATION
COM
09627Y109
47380
878875
SH
DFND
1,2,3
878875
0
0
ALLENA PHARMACEUTICALS, INC.
COM
018119107
15211
2790964
SH
DFND
1,2,3
2790964
0
0